Through its profile on Pharmalicensing, California based Cosmederm has been introduced to a number of new potential partners with whom it is now in discussions regarding possible business relationships. Sean Edwards, CEO at Cosmederm spoke to Pharmalicensing about the success he and his company have achieved by posting the company and its licensing details on the site. More

Japan being the second largest pharmaceutical industry in the world, worth $60.3 billion as of 2005, is yet to gain a strong foothold in developing new drugs and in outsourcing. What is holding back this giant from attracting investments to help speed the drug approvals? Can speedy drug approvals help clinical outsourcing within Japan? More

Next February WBR is host to pharma's premier and most exclusive global biopartnering event, BioBusiness 2008. Designed especially for pharma companies looking to in-license or partner and small biotechs requiring funding, out-licensing or partners, the event has something for everyone. More

'Easily accessible' and 'not too expensive' are the two of the main reasons behind Pantarhei Biosciences of the Netherlands decision to join Pharmalicensing and subscribe to the managed partnering service in early 2007. More

In the first seven months of 2007, the life sciences and healthcare sector witnessed the initiation and/or completion of 133 M&As. Taken together, these deals span the gamut - from diagnostic assays and research tools to specialty and generic pharma companies, from contract manufacturing and genetic analysis to product lines and business units. More

Epilepsy, one of the oldest conditions known to mankind, is a neurological disorder characterised by recurrent, transient seizures caused by a disturbance in the electrical activity of the central nervous system. According to the World Health Organisation, up to 50 million people worldwide, equating to a prevalence of at least 50 per 100,000 of the general population will have epilepsy at any one time. More

In today's fervently age-conscious society, where maturity is widely regarded as a social handicap on a par with halitosis, why should women hoping to maintain their youthful good looks spend their days at sea level? And what could this possibly have to do with the adrenal gland? The answer is that women who live at high altitudes appear to age more quickly, because of lower levels of the adrenal hormones DHEA and DHEAS (dehydroepiandrosterone and dehydroepiandrosterone sulphate). However, a healthy adrenal gland does much more than act as endogenous botox... More

Bile has had a very bad press over the years. According to the humoral theory of medicine developed by the Ancient Greeks, the body consisted of four fluids (or humours), each of which gave off a specific vapour that ascended to the brain and defined the personality. More

The softgel delivery system offers improved, rapid and consistent absorption of hydrophobic drugs. More

If you had contracted tuberculosis (TB) in the first half of the last century, the most advanced treatment available was rest in a sanatorium and collapsing the lung; not surprisingly, the chances of survival were only around 50%. Cure rates soared in the developed world with the advent of antibiotics, but the latter years of the twentieth century saw a resurgence of the disease, with the emergence of multi-drug resistance and the deadly combination of tuberculosis and AIDS. Incidence rates have since generally declined, but the numbers involved are truly staggering. More